SCHEMBL4772004

SCHEMBL4772004

CCCN(c1ncc2c(=O)c(C(=O)NC)cn(-c3ccccc3)c2n1)n1ccnc1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.41
PDE4A P27815 5/20 0.41
CSF1R P07333 13/20 0.39
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768307 0.91 CSF1R (0.47) KCNH2PDE4ACSF1R
SCHEMBL4773612 0.89 CSF1R (0.40) KCNH2PDE4ACSF1RKDM4EMAPK1
SCHEMBL4775827 0.77 CSF1R (0.59) CSF1R
SCHEMBL4777309 0.76 CSF1R (0.57) CSF1R
SCHEMBL3292502 0.74 CSF1R (0.62) KCNH2PDE4ACSF1RKDM4EMAPK1
SCHEMBL3293467 0.71 CSF1R (0.49) KCNH2PDE4ACSF1RKDM4E
SCHEMBL3293704 0.70 CSF1R (0.53) KCNH2PDE4ACSF1R
SCHEMBL11016385 0.70 CSF1R (0.46) KCNH2PDE4ACSF1RKDM4EMAPK1
SCHEMBL3291712 0.69 CSF1R (0.54) KCNH2PDE4ACSF1RKDM4E
SCHEMBL3291667 0.67 CSF1R (0.53) KCNH2PDE4ACSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945637-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-07-23 EP claimed
WO-2007033137-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2007-03-22 WO claimed
EP-1945637-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-07-23 EP disclosed
WO-2007033137-A1 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2007-03-22 WO disclosed